Search

everythinglearnresearchcommunity

for

Search:↓

Hair graying may be caused by stem cell depletion from stress or melanocyte damage.

Genetics and nutritional deficiencies are key factors in premature graying of hair.

A girl with a rare genetic condition affecting hair and nails also developed a common type of hair loss, suggesting a possible genetic link.

New genetic discoveries may lead to better treatments for alopecia areata.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Plant extracts may help prevent or reverse hair graying.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Childhood Alopecia Areata causes hair loss and requires varied treatments, with psychological support being crucial.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.

Certain genetic variations in IL18 may increase the risk of alopecia areata in Koreans.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

Some diets and supplements might help with skin disorders, but their effectiveness varies and more research is needed.

Familial frontal fibrosing alopecia is rare, mostly affects women, and often occurs between sisters or mother-daughter pairs.

The convention discussed various skin conditions and treatments, and highlighted the importance of vaccinations for patients on immune-altering medications.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

New therapies are being developed that target integrin pathways to treat various diseases.

Cronkhite-Canada syndrome is a rare, non-inherited condition causing various symptoms like polyps, hair loss, and weight loss.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

The document concludes that various skin conditions have specific characteristics and treatments, and highlights the importance of vitamin D in managing these dermatological issues.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

Microneedles combined with conventional therapies show promise in treating alopecia areata.

The complement system might be involved in the development of alopecia areata and could lead to new treatments.